Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.

Microbial pathogenesis - 1 Jan 1990

Olander R M, Muotiala A, Karvonen M, Kuronen T, Runeberg-Nyman K

Abstract excerpt

The protective capacities of antibodies to pertussis toxin (PT) were compared with antibodies to several other pertussis antigens in an experimental murine model of intranasal infection with Bordetella pertussis. Protection from lethal challenge was achieved by passive immunization with mouse antisera to whole cells of the virulent B. pertussis BP338(Vir+) and its Tn5-generated mutants, BP353(Fha-),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to DNA Transposable Elements

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hemagglutinins

Share to Immunization, Passive

Share to Mutation

Share to Neutralization Tests

Share to Pertussis Toxin

Source

Identifiers

PMID: 2159104
DOI: 10.1016/0882-4010(90)90006-c

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.PMID 2159104Read ↗

Mucosal and Systemic Antibodies Associated with Clinical Protection in a Pertussis Controlled Human Infection ModelSemantic proximity Read ↗

Pertussis: current concepts of pathogenesis and preventionSemantic proximity Read ↗

[Immunogenicity and safety of vaccine preparations based on circulating Bordetella pertussis strains].Semantic proximity Read ↗

Acellular pertussis vaccines and the role of pertactin and fimbriaeSemantic proximity Read ↗

Immunodominant Domains Present on theBordetella pertussisVaccine Component Filamentous HemagglutininSemantic proximity Read ↗

Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboonsSemantic proximity Read ↗

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.Semantic proximity Read ↗

Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae.Semantic proximity Read ↗

Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.Semantic proximity Read ↗

Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.Semantic proximity Read ↗

Serum resistance in bvg-regulated mutants of Bordetella pertussis.Semantic proximity Read ↗

The Protective Role of Maternally Derived Antibodies Against Bordetella Pertussis in Young InfantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.